Read More Pharma Industry News InnoCare and KeyMed license CD20xCD3 antibody ICP-B02 to Prolium for global development In a move poised to reshape the landscape of cancer and autoimmune treatments, InnoCare Pharma and KeyMed Biosciences… byPallavi MadhirajuJanuary 20, 2025